SafeGuard:
Redefining
Surgery
LeakGuard™: the only FDA breakthrough product of its kind.
SafeGuard Surgical is redefining post-operative care with groundbreaking innovation. Our scalable surgical platform is built to eliminate complications, reduce costs, and improve patient outcomes.
At the core of this revolution is LeakGuard™, the only FDA breakthrough stent of its kind, designed to prevent surgical leaks without the need for removal.
Surgical complications drive up costs and prolong recovery, creating unnecessary risks for patients and burdens on healthcare systems. SafeGuard Surgical delivers a smarter, more efficient solution—one that enhances healing, cuts expenses, and eliminates waste. With a patented, U.S.-manufactured technology, we’re not just improving surgery—we’re setting a new industry standard.
Our founder
DR. SCOTT KELLEY
Dr. Kelley serves as CEO of SafeGuard Surgical. As an innovator and an accomplished Ivy League cancer surgeon, he has held leadership roles at some of the largest healthcare institutions.
As an accomplished inventor and innovator, he serves as a global healthcare advisor to countries and multinational companies on emerging technology.
Evolution of Leakguard™
SafeGuard is Trademarked and Incorporated
Dr. Kelley sells his medical practice to launch SafeGuard Surgical
Prototype developed and successfully tested
Family/friends investment round led by NFL QB Jameis Winston
FDA Breakthrough Designation
Fund led by philanthropist Tom Pepin
Our Advisors

Eamonn Hobbs

justin Chickles

Deb Ramsdel

Dean Hu

Vishal Verma

Jill Kelley

Richard Toren
Safer surgeries, healthier humans.